Cargando…

Immune Prophylaxis and Therapy for Human Cytomegalovirus Infection

Human Cytomegalovirus (HCMV) infection is widespread and can result in severe sequelae in susceptible populations. Primary HCMV infection of naïve individuals results in life-long latency characterized by frequent and sporadic reactivations. HCMV infection elicits a robust antibody response, includi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Struble, Evi B., Murata, Haruhiko, Komatsu, Takashi, Scott, Dorothy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395925/ https://www.ncbi.nlm.nih.gov/pubmed/34445434 http://dx.doi.org/10.3390/ijms22168728

Ejemplares similares

Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
por: Struble, Evi B., et al.
Publicado: (2023)

Human Antibodies Can Cross Guinea Pig Placenta and Bind Its Neonatal Fc Receptor: Implications for Studying Immune Prophylaxis and Therapy during Pregnancy
por: Struble, Evi Budo, et al.
Publicado: (2012)

Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection
por: Ouellette, Christopher P.
Publicado: (2022)

Letermovir for cytomegalovirus prophylaxis
Publicado: (2019)

Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice
por: Xu, Yanqun, et al.
Publicado: (2020)

Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection
por: Britt, William J.
Publicado: (2018)

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy
por: Ko, Eun Jeong, et al.
Publicado: (2019)

Entry and Disposition of Zika Virus Immune Complexes in a Tissue Culture Model of the Maternal-Fetal Interface
por: Xu, Yanqun, et al.
Publicado: (2021)

Human Cytomegalovirus Manipulation of Latently Infected Cells
por: Sinclair, John H., et al.
Publicado: (2013)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression
por: Cox, Momodou, et al.
Publicado: (2021)

Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients
por: Körholz, Katharina F., et al.
Publicado: (2022)

Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection
por: Schleiss, Mark R.
Publicado: (2013)

Cytomegalovirus Infections in Children with Primary and Secondary Immune Deficiencies
por: Bateman, Caroline M., et al.
Publicado: (2021)

Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
por: Moazen, Bahareh, et al.
Publicado: (2016)

Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology
por: Gredmark-Russ, Sara, et al.
Publicado: (2012)

Intrinsic Immune Mechanisms Restricting Human Cytomegalovirus Replication
por: Schilling, Eva-Maria, et al.
Publicado: (2021)

Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
por: Hashim, Faris, et al.
Publicado: (2014)

Effectiveness of valacyclovir prophylaxis against the occurrence of cytomegalovirus infection in kidney transplant recipients
por: Park, Woo Yeong, et al.
Publicado: (2020)

Nanoluciferase Reporter Zika Viruses as Tools for Assessing Infection Kinetics and Antibody Potency
por: Xu, Yanqun, et al.
Publicado: (2023)

Splenic Infarction in Acute Cytomegalovirus and Human Parvovirus Concomitant Infection
por: Harada, Tomoya, et al.
Publicado: (2018)

Antiviral prophylaxis inhibits cytomegalovirus reactivation in critical illness
por: Cowley, NJ, et al.
Publicado: (2015)

Cytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic Transplantation
por: Rea, Federico, et al.
Publicado: (2016)

2648. Terminating the Troll of Transplantation: Letermovir for Cytomegalovirus Prophylaxis
por: Hedvat, Jason, et al.
Publicado: (2019)

The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)

Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults
por: Politikos, Ioannis, et al.
Publicado: (2022)

Dosing Considerations for Antibodies Against COVID-19
por: Tegenge, Million A., et al.
Publicado: (2020)

A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity
por: Geisler, Jürgen, et al.
Publicado: (2019)

1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients
por: Huang, Glen, et al.
Publicado: (2020)

Common Polymorphisms in the Glycoproteins of Human Cytomegalovirus and Associated Strain-Specific Immunity
por: Wang, Hsuan-Yuan, et al.
Publicado: (2021)

The Immune Response Against Human Cytomegalovirus Links Cellular to Systemic Senescence
por: J. Heath, John, et al.
Publicado: (2020)

Feeling manipulated: cytomegalovirus immune manipulation
por: Miller-Kittrell, Mindy, et al.
Publicado: (2009)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Subversion of Immune Response by Human Cytomegalovirus
por: Patro, A. Raj Kumar
Publicado: (2019)

Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
por: Martino, Massimo, et al.
Publicado: (2021)

Adaptive and Innate Immune Cells in Fetal Human Cytomegalovirus-Infected Brains
por: Sellier, Yann, et al.
Publicado: (2020)

Congenital human cytomegalovirus infection and neurologic diseases in newborns
por: Zhang, Xin-Yan, et al.
Publicado: (2019)

Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
por: Chen, Shiu-Jau, et al.
Publicado: (2022)

An Update on Current Antiviral Strategies to Combat Human Cytomegalovirus Infection
por: Panda, Kingshuk, et al.
Publicado: (2023)

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation
por: Maertens, Johan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qe6c81qkognjcc8l52pdkvg8dr